67 phenotypes from 11 alleles in 16 genetic backgrounds

Allelic Composition Genetic Background	Annotated Term	Reference
H2-Ab1b-tm1.1Jssh/H2-Ab1b-tm1.1Jssh C57BL/6-H2-Ab1b-tm1.1Jssh	abnormal dendritic cell antigen presentation	J:201198
	abnormal T cell differentiation	J:201198
	decreased regulatory T cell number	J:201198
H2-Ab1b-tm1.1Koni/H2-Ab1b-tm1.1Koni Tg(Tek-cre)12Flv/0 involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J	preweaning lethality, incomplete penetrance	J:131774
H2-Ab1b-tm1.1Sish/H2-Ab1b-tm1.1Sish involves: 129S1/Sv * 129X1/SvJ	abnormal dendritic cell physiology	J:157516
	decreased interleukin-12 secretion	J:157516
	decreased tumor necrosis factor secretion	J:157516
H2-Ab1b-tm1Doi/H2-Ab1+ involves: 129S2/SvPas * C57BL/6 * NOD/Lt	insulitis	J:93557
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi involves: 129S2/SvPas	abnormal neuron proliferation	J:170591
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi involves: 129S2/SvPas * C57BL/6	abnormal B cell physiology	J:65736
	abnormal CD4-positive, alpha beta T cell morphology	J:65736
	abnormal CD4-positive, alpha-beta T cell physiology	J:65736
	abnormal cytokine secretion	J:64283
	abnormal immune system cell morphology	J:65736
	abnormal immune system morphology	J:65736
	abnormal immune system organ morphology	J:65736
	abnormal immune system physiology	J:65736
	abnormal lymph node cell ratio	J:65736
	abnormal spleen B cell follicle morphology	J:65736
	abnormal spleen marginal zone morphology	J:65736
	abnormal spleen morphology	J:65736
	abnormal spleen periarteriolar lymphoid sheath morphology	J:65736
	abnormal T cell physiology	J:65736
	absent spleen germinal center	J:65736
	decreased CD4-positive, alpha-beta T cell number	J:51885, J:65736
	decreased IgG1 level	J:65736
	decreased susceptibility to parasitic infection	J:64283
	increased CD4-positive, alpha-beta T cell number	J:64283
	increased CD8-positive, alpha-beta T cell number	J:64283, J:65736
	increased susceptibility to parasitic infection	J:64283
	postnatal growth retardation	J:65736
	reduced fertility	J:65736
H2-Ab1b-tm1Doi/H2-Ab1b-tm1Doi involves: 129S2/SvPas * C57BL/6 * NOD/Lt	insulitis	J:93557
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru B6.129S2-H2-Ab1b-tm1Gru	abnormal B cell physiology	J:91341
	abnormal lymphocyte physiology	J:91341
	decreased CD4-positive, alpha-beta T cell number	J:91341
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru involves: 129S2/SvPas	abnormal artery development	J:134875
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru involves: 129S2/SvPas * C57BL/6	abnormal level of surface class II molecules	J:67941
	decreased CD4-positive, alpha-beta T cell number	J:67941
	decreased IgG1 level	J:67941
	decreased IgM level	J:67941
	decreased single-positive T cell number	J:67941
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru involves: 129S2/SvPas * C57BL/6J	abnormal humoral immune response	J:74418
	abnormal response to transplant	J:91742
	decreased CD4-positive, alpha-beta T cell number	J:74418
	decreased IgG level	J:74418
	increased CD8-positive, alpha-beta T cell number	J:74418
	increased IgM level	J:74418
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru NOD.129S2-H2-Ab1b-tm1Gru	normal cardiovascular system phenotype	J:86540
	normal immune system phenotype	J:86540
H2-Ab1b-tm1Gru/H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru/0 B6.Cg-H2-Ab1b-tm1Gru Tg(Ab1TL)1Gru	abnormal CD4-positive T cell differentiation	J:91341
	abnormal macrophage antigen presentation	J:91341
	abnormal professional antigen presenting cell physiology	J:91341
H2-Ab1b-tm1Hpl/H2-Ab1+ involves: 129S4/SvJae	no abnormal phenotype detected	J:78940
H2-Ab1b-tm1Koni/H2-Ab1b-tm1.1Koni Tg(Tek-cre)12Flv/0 involves: 129X1/SvJ * C3H * C57BL/6 * C57BL/6J	abnormal CD4-positive, CD25-positive, alpha-beta regulatory T cell morphology	J:131774
	abnormal T cell activation	J:131774
	decreased CD4-positive, CD25-positive, alpha-beta regulatory T cell number	J:131774
	decreased level of surface class II molecules	J:131774
	normal immune system phenotype	J:131774
	increased CD4-positive, alpha-beta T cell number	J:131774
H2-Ab1b-tm1Koni/H2-Ab1b-tm1Koni involves: 129X1/SvJ * C57BL/6J	no abnormal phenotype detected	J:75115
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug involves: C57BL/6	abnormal B cell physiology	J:204951
	abnormal dendritic cell physiology	J:204951
	absent CD4-positive, alpha-beta T cells	J:204951
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:204951
H2-Ab1b-tm1Wug/H2-Ab1b-tm1Wug Cd19tm1(cre)Cgn/Cd19+ involves: 129S2/SvPas * C57BL/6	abnormal B cell physiology	J:204951
	abnormal dendritic cell physiology	J:204951
	decreased susceptibility to experimental autoimmune encephalomyelitis	J:204951
	normal immune system phenotype	J:204951
H2-Ab1bm12/H2-Ab1bm12 B6(C)-H2-Ab1bm12/KhEgJ	abnormal level of surface class II molecules	J:100194
	abnormal T cell physiology	J:100123
	decreased susceptibility to autoimmune disorder	J:100123
	decreased susceptibility to experimental autoimmune myasthenia gravis	J:100213
	decreased susceptibility to parasitic infection	J:48242
H2-Ab1bm12/H2-Ab1bm12 NZB.B6(C)-H2-Ab1bm12	abnormal immunoglobulin level	J:104189
	abnormal level of surface class II molecules	J:104189
	abnormal response/metabolism to endogenous compounds	J:104189
	autoimmune response	J:4554
	decreased CD8-positive, alpha-beta T cell number	J:4554
	hemolytic anemia	J:4554
	increased anti-double stranded DNA antibody level	J:104189
	increased anti-erythrocyte antigen antibody level	J:4554
	increased anti-single stranded DNA antibody level	J:104189
	increased B cell number	J:104189
	increased CD4-positive, alpha-beta T cell number	J:4554
	increased double-negative T cell number	J:4554
	increased urine protein level	J:104189
	premature death	J:104189
H2-Ab1g7-em1Ygch/H2-Ab1g7-em1Ygch NOD/ShiLtJ-H2-Ab1g7-em1Ygch	decreased CD4-positive, alpha-beta T cell number	J:101977